tradingkey.logo

Quantum-Si Inc

QSI
1.270USD
0.000
Close 12/22, 16:00ETQuotes delayed by 15 min
273.63MMarket Cap
LossP/E TTM

Quantum-Si Inc

1.270
0.000
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Quantum-Si Inc

Currency: USD Updated: 2025-12-22

Key Insights

Quantum-Si Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 169/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.83.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quantum-Si Inc's Score

Industry at a Glance

Industry Ranking
169 / 404
Overall Ranking
297 / 4578
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Buy
Current Rating
2.833
Target Price
+95.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Quantum-Si Inc Highlights

StrengthsRisks
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.06M.
Fairly Valued
The company’s latest PE is -1.91, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 58.86M shares, increasing 6.77% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 8.71M shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-22

The current financial score of Quantum-Si Inc is 5.91, ranking 322/404 in the Biotechnology & Medical Research industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 552.00K, representing a year-over-year decrease of 29.86%, while its net profit experienced a year-over-year decrease of 41.05%.

Score

Industry at a Glance

Previous score
5.91
Change
0

Financials

7.04

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.53

Operational Efficiency

2.83

Growth Potential

5.09

Shareholder Returns

7.07

Quantum-Si Inc's Company Valuation

Currency: USD Updated: 2025-12-22

The current valuation score of Quantum-Si Inc is 7.00, ranking 196/404 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.91, which is -47.75% below the recent high of -1.00 and -218.02% above the recent low of -6.08.

Score

Industry at a Glance

Previous score
7.00
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 169/404
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-22

The current earnings forecast score of Quantum-Si Inc is 7.33, ranking 296/404 in the Biotechnology & Medical Research industry. The average price target for Quantum-Si Inc is 2.50, with a high of 4.00 and a low of 2.00.

Score

Industry at a Glance

Previous score
7.33
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
2.833
Target Price
+95.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

534
Total
6
Median
6
Average
Company name
Ratings
Analysts
Quantum-Si Inc
QSI
3
CRISPR Therapeutics AG
CRSP
30
argenx SE
ARGX
25
Intellia Therapeutics Inc
NTLA
25
IQVIA Holdings Inc
IQV
25
Ionis Pharmaceuticals Inc
IONS
24
1
2
3
...
107

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-22

The current price momentum score of Quantum-Si Inc is 6.75, ranking 205/404 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 1.48 and the support level at 1.12, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.61
Change
0.14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.010
Neutral
RSI(14)
40.760
Neutral
STOCH(KDJ)(9,3,3)
27.366
Neutral
ATR(14)
0.095
Low Volatility
CCI(14)
-49.622
Neutral
Williams %R
75.000
Sell
TRIX(12,20)
-0.851
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.236
Buy
MA10
1.296
Sell
MA20
1.335
Sell
MA50
1.670
Sell
MA100
1.498
Sell
MA200
1.515
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-22

The current institutional shareholding score of Quantum-Si Inc is 3.00, ranking 197/404 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 30.10%, representing a quarter-over-quarter decrease of 29.42%. The largest institutional shareholder is The Vanguard, holding a total of 8.71M shares, representing 4.46% of shares outstanding, with 5.74% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Rothberg (Jonathan M)
13.73M
--
BlackRock Institutional Trust Company, N.A.
9.99M
+13.17%
The Vanguard Group, Inc.
Star Investors
8.67M
+25.78%
ARK Investment Management LLC
Star Investors
7.96M
+1.94%
Amova Asset Management Co., Ltd.
5.62M
-3.27%
Geode Capital Management, L.L.C.
3.45M
+15.12%
Rakin (Kevin L)
2.92M
+0.23%
State Street Investment Management (US)
2.76M
+12.32%
Millennium Management LLC
3.78M
-3.94%
Northern Trust Investments, Inc.
2.26M
+125.57%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-22

The current risk assessment score of Quantum-Si Inc is 2.55, ranking 229/404 in the Biotechnology & Medical Research industry. The company's beta value is 3.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.55
Change
0
Beta vs S&P 500 index
3.01
VaR
+8.80%
240-Day Maximum Drawdown
+71.39%
240-Day Volatility
+116.17%

Return

Best Daily Return
60 days
+24.55%
120 days
+24.55%
5 years
+119.59%
Worst Daily Return
60 days
-10.24%
120 days
-14.72%
5 years
-32.15%
Sharpe Ratio
60 days
-0.18
120 days
-0.39
5 years
+0.14

Risk Assessment

Maximum Drawdown
240 days
+71.39%
3 years
+83.73%
5 years
+95.61%
Return-to-Drawdown Ratio
240 days
-0.89
3 years
-0.18
5 years
-0.19
Skewness
240 days
+0.60
3 years
+4.71
5 years
+4.63

Volatility

Realised Volatility
240 days
+116.17%
5 years
+114.07%
Standardised True Range
240 days
+12.67%
5 years
+21.19%
Downside Risk-Adjusted Return
120 days
-82.78%
240 days
-82.78%
Maximum Daily Upside Volatility
60 days
+101.86%
Maximum Daily Downside Volatility
60 days
+70.71%

Liquidity

Average Turnover Rate
60 days
+4.10%
120 days
+4.19%
5 years
--
Turnover Deviation
20 days
-16.63%
60 days
-4.49%
120 days
-2.48%

Peer Comparison

Biotechnology & Medical Research
Quantum-Si Inc
Quantum-Si Inc
QSI
5.90 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amicus Therapeutics Inc
Amicus Therapeutics Inc
FOLD
8.80 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Krystal Biotech Inc
Krystal Biotech Inc
KRYS
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Charles River Laboratories International Inc
Charles River Laboratories International Inc
CRL
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc
MDGL
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
IQVIA Holdings Inc
IQVIA Holdings Inc
IQV
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Quantum-Si Inc?

The TradingKey Stock Score provides a comprehensive assessment of Quantum-Si Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Quantum-Si Inc’s performance and outlook.

How do we generate the financial health score of Quantum-Si Inc?

To generate the financial health score of Quantum-Si Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Quantum-Si Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Quantum-Si Inc.

How do we generate the company valuation score of Quantum-Si Inc?

To generate the company valuation score of Quantum-Si Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Quantum-Si Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Quantum-Si Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Quantum-Si Inc.

How do we generate the earnings forecast score of Quantum-Si Inc?

To calculate the earnings forecast score of Quantum-Si Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Quantum-Si Inc’s future.

How do we generate the price momentum score of Quantum-Si Inc?

When generating the price momentum score for Quantum-Si Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Quantum-Si Inc’s prices. A higher score indicates a more stable short-term price trend for Quantum-Si Inc.

How do we generate the institutional confidence score of Quantum-Si Inc?

To generate the institutional confidence score of Quantum-Si Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Quantum-Si Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Quantum-Si Inc.

How do we generate the risk management score of Quantum-Si Inc?

To assess the risk management score of Quantum-Si Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Quantum-Si Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Quantum-Si Inc.
KeyAI